U.S. Pharmaceuticals Prices Surge
This is a U.S. news story, published by Yahoo Finance, that relates primarily to Niemann news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsNiemann news
For more Niemann news, you can click here:
more Niemann newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Drug pricing. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest overall prescription drug spending news, prescription costs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
drug costsReuters
•Health
Health
Prices for new US drugs doubled in 4 years as focus on rare disease grows

87% Informative
Prices for newly-launched pharmaceuticals more than doubled last year compared to 2021 .
Increase in prices has occurred even as the U.S. government tries to rein in prescription costs.
Percentage of drugs launched for rare diseases rose to 72% in 2024 from 51% in 2019 .
Highest price for a drug taken consistently was over $1 million for Niemann -pick disease type C.
VR Score
94
Informative language
99
Neutral language
62
Article tone
formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links